Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.88 USD | -0.81% | +3.39% | -27.92% |
05-08 | Mizuho Adjusts uniQure's Price Target to $6 From $7, Keeps Neutral Rating | MT |
05-07 | UniQure N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.92% | 237M | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.30% | 21.93B | |
-12.15% | 22.34B | |
-5.85% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- QURE Stock
- News uniQure N.V.
- UniQure Says its Huntington's Disease Gene Therapy Candidate Showed Potential Clinical Benefit in Phase 1/2 Trial